{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:32:34Z","timestamp":1789435954929,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jaci.2017.01.014","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T15:18:47Z","timestamp":1486653527000},"page":"1277-1287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma"],"prefix":"10.1016","volume":"140","author":[{"given":"Stanley J.","family":"Szefler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Thomas","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Boner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Laki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"El Azzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Moroni-Zentgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Finnigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckard","family":"Hamelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2017.01.014_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1398-9995.2004.00526.x","article-title":"Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report","volume":"59","author":"Masoli","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2017.01.014_bib2","series-title":"Asthma Facts and FAQs","year":"2014"},{"key":"10.1016\/j.jaci.2017.01.014_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1081-1206(10)60713-2","article-title":"The impact of inadequately controlled asthma in urban children on quality of life and productivity","volume":"98","author":"Schmier","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaip.2015.08.017","article-title":"The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial","volume":"4","author":"Paggiaro","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2017.01.014_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(15)00031-4","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-15-61","article-title":"Tiotropium Respimat\u00ae in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma","volume":"15","author":"Beeh","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2017.01.014_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rmed.2014.12.005","article-title":"Once-daily tiotropium Respimat\u00ae 5 \u03bcg is an efficacious 24-h bronchodilator in adults with symptomatic asthma","volume":"109","author":"Timmer","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib8","doi-asserted-by":"crossref","first-page":"e0124109","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium Respimat\u00ae is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2017.01.014_bib9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.rmed.2014.06.011","article-title":"Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study","volume":"108","author":"Vogelberg","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2016.01.011","article-title":"Tiotropium add-on therapy in adolescents with moderate asthma: a 1-year randomized controlled trial","volume":"138","author":"Hamelmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01100-2016","article-title":"A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma","volume":"49","author":"Hamelmann","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2017.01.014_bib13","series-title":"Global Strategy for Asthma Management and Prevention. Updated 2016","year":"2016"},{"key":"10.1016\/j.jaci.2017.01.014_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/pcrj.2002.13","article-title":"The burden of paediatric asthma is higher than health professionals think: results from the Asthma In Real Life (AIR) study","volume":"11","author":"Price","year":"2002","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaci.2017.01.014_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1368-5031.2006.00798.x","article-title":"Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice","volume":"60","author":"Gustafsson","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaci.2017.01.014_bib16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2015.07.007","article-title":"New and future strategies to improve asthma control in children","volume":"136","author":"Anderson","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib17","first-page":"1346","article-title":"Determinants of patient adherence to an aerosol regimen","volume":"50","author":"Rau","year":"2005","journal-title":"Respir Care"},{"key":"10.1016\/j.jaci.2017.01.014_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.anai.2011.01.016","article-title":"The potential of asthma adherence management to enhance asthma guidelines","volume":"106","author":"Weinstein","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11882-011-0227-2","article-title":"Medication adherence in the asthmatic child and adolescent","volume":"11","author":"Desai","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2017.01.014_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1183\/09031936.00104809","article-title":"Problematic severe asthma in children, not one problem but many: a GA2LEN initiative","volume":"36","author":"Hedlin","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2017.01.014_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ppul.20650","article-title":"The challenge of asthma in adolescence","volume":"42","author":"de Benedictis","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaci.2017.01.014_bib22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/ppul.22761","article-title":"What drives prescribing of asthma medication to preschool wheezing children? A\u00a0primary care study","volume":"48","author":"Montella","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaci.2017.01.014_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2466-10-29","article-title":"Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study","volume":"10","author":"Thomas","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09059180.00001209","article-title":"Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK","volume":"18","author":"Demoly","year":"2009","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2017.01.014_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4104\/pcrj.2011.00056","article-title":"Understanding patients with asthma\u00a0and COPD: insights from a European study","volume":"20","author":"Partridge","year":"2011","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaci.2017.01.014_bib27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/all.12275","article-title":"EAACI position statement on asthma exacerbations and severe asthma","volume":"68","author":"Custovic","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2017.01.014_bib28","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1164\/rccm.201309-1700OC","article-title":"Trajectories\u00a0of lung function during childhood","volume":"189","author":"Belgrave","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jaci.2014.12.1942","article-title":"Seasonal risk factors for asthma exacerbations among inner-city children","volume":"135","author":"Teach","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1067\/mai.2001.111590","article-title":"FEV1 is associated with risk of asthma attacks in a pediatric population","volume":"107","author":"Fuhlbrigge","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1411532","article-title":"Lung-function trajectories leading to chronic obstructive pulmonary disease","volume":"373","author":"Lange","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib32","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa1513737","article-title":"Patterns of growth and decline in lung function in persistent childhood asthma","volume":"374","author":"McGeachie","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.DBP.0000267557.80834.e5","article-title":"Developmental and behavioral comorbidities of asthma in children","volume":"28","author":"Blackman","year":"2007","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.jaci.2017.01.014_bib34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archpedi.154.9.923","article-title":"Nocturnal asthma in children affects school attendance, school performance, and parents' work attendance","volume":"154","author":"Diette","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1034\/j.1399-3038.2000.00089.x","article-title":"Intervention models on psycho-social health in families with an asthmatic child","volume":"11","author":"Gustafsson","year":"2000","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/adc.78.5.413","article-title":"Sleep and psychological disturbance in nocturnal asthma","volume":"78","author":"Stores","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaci.2017.01.014_bib37","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1542\/peds.2005-1055","article-title":"Impact of physician asthma care education on patient outcomes","volume":"117","author":"Cabana","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2017.01.014_bib38","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2017.01.014_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2017.01.014_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jaci.2015.03.023","article-title":"Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire: systematic review and network meta-analysis","volume":"136","author":"Bateman","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/02770903.2012.690481","article-title":"The\u00a0utility of forced expiratory flow between 25% and 75% of vital capacity in\u00a0predicting childhood asthma morbidity and severity","volume":"49","author":"Rao","year":"2012","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2017.01.014_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2010.05.016","article-title":"Forced expiratory flow between 25% and 75% of vital capacity and FEV1\/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values","volume":"126","author":"Simon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1164\/rccm.200308-1178OC","article-title":"Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function","volume":"170","author":"Bacharier","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.anai.2015.11.011","article-title":"Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment","volume":"116","author":"Quezada","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib46","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.1542\/peds.2008-0292","article-title":"At what age do children start taking daily asthma medicines on their own?","volume":"122","author":"Orrell-Valente","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2017.01.014_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2011.06.004","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma","volume":"128","author":"Bateman","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.01.014_bib48","first-page":"CD011438","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma","volume":"6","author":"Kew","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2017.01.014_bib49","first-page":"CD010005","article-title":"Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews","volume":"10","author":"Cates","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2017.01.014_bib50","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMp1104375","article-title":"Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma","volume":"364","author":"Chowdhury","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib51","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMoa1606356","article-title":"Safety of adding salmeterol to fluticasone propionate in children with asthma","volume":"375","author":"Stempel","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib52","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1056\/NEJMoa1511049","article-title":"Serious asthma events with fluticasone plus salmeterol versus fluticasone alone","volume":"374","author":"Stempel","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib53","doi-asserted-by":"crossref","first-page":"973849","DOI":"10.1155\/2011\/973849","article-title":"Adherence with preventive medication in childhood asthma","volume":"2011","author":"Burgess","year":"2011","journal-title":"Pulm Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib54","first-page":"197","article-title":"The impact of adherence and disease control on resource use and charges in patients with mild asthma managed on inhaled corticosteroid agents","volume":"4","author":"Navaratnam","year":"2010","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaci.2017.01.014_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-10-1","article-title":"Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study","volume":"10","author":"Price","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaci.2017.01.014_bib56","first-page":"CD010314","article-title":"Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews","volume":"2","author":"Cates","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2017.01.014_bib57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1542\/peds.99.5.655","article-title":"Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment","volume":"99","author":"Simons","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2017.01.014_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.06.018","article-title":"A review of the development of Respimat\u00ae Soft Mist\u2122 Inhaler","volume":"283","author":"Dalby","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jaci.2017.01.014_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1651-2227.2002.tb01688.x","article-title":"Determinants of correct inhalation technique in children attending a hospital-based asthma clinic","volume":"91","author":"Kamps","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaci.2017.01.014_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/fampra\/13.1.35","article-title":"Effects of instruction by practice assistants on inhaler technique and respiratory symptoms of patients: a controlled randomized videotaped intervention study","volume":"13","author":"Verver","year":"1996","journal-title":"Fam Pract"},{"key":"10.1016\/j.jaci.2017.01.014_bib61","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1183\/09031936.00136408","article-title":"Small studies: strengths and limitations","volume":"32","author":"Hackshaw","year":"2008","journal-title":"Eur Respir J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167491730218X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167491730218X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:05:19Z","timestamp":1758791119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167491730218X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S009167491730218X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2017.01.014","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2017.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}